Skip to content

PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH RISK FACTORS

A STUDY ON PREVALENCE OF PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH HBA1C AND OTHER RISK FACTORS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052745
Enrollment
200
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

DR LAKSHIKA SAINI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: People diagnosed with type 2 diabetes mellitus with HbA1c criteria fulfilling the T2DM diagnosis (as blood sugar â??fasting/pp can vary due to multiple reasons among admitted patients with various diagnosis)

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes mellitus patients 2. Pregnancy 3. Patients with other known causes of peripheral neuropathy such as alcoholic, uremia, tuberculosis, HIV etc. 4. Patients on certain drugs having peripheral neuropathy as established toxicity.

Design outcomes

Primary

MeasureTime frame
The outcomes of this study will primarily be the clinical examination findings, the MNSI scores of the 2 steps and the score in monofilament testing of the sensation of the feet â?? giving the presence, prevalence and severity of the neuropathic associated with diabetes. The NCV test results will have a corroborative value to the primary outcomes.Timepoint: AT BASELINE

Secondary

MeasureTime frame
1. The duration of diabetes, HbA1C values, BMI and the dyslipidemia correlation and deduced association. 2. Prevalence and severity of neuropathic symptoms at different hba1c values and aforementioned risk factors.Timepoint: AT BASELINE

Countries

India

Contacts

Public ContactDR LAKSHIKA SAINI

MAX SUPERSPECIALTY HOSPITAL VAISHALI

drajaykumargupta@gmail.com9871134389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026